Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Cardlytics, Inc. due to allegations of violations of federal securities laws, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation and Claims - The law firm is urging investors who suffered losses exceeding $50,000 in Cardlytics between March 14, 2024, and August 7, 2024, to discuss their legal options [1]. - A federal securities class action has been filed against Cardlytics, with a deadline of March 25, 2025, for investors to seek the role of lead plaintiff [2][7]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 2: Allegations Against Cardlytics - The complaint alleges that Cardlytics and its executives made false or misleading statements and failed to disclose critical information regarding consumer engagement and revenue growth [4]. - Specific allegations include the inability to increase billings in line with consumer engagement, leading to a significant risk of revenue growth slowing or declining [4]. Group 3: Financial Performance and Stock Impact - On May 8, 2024, Cardlytics reported a revenue increase of only 8% year-over-year, despite a 12% increase in billings, attributed to a 20.2% rise in consumer incentives, resulting in a stock price drop of $5.33 (36.5%) [5]. - Following the release of second-quarter 2024 results on August 7, 2024, which showed a 9% year-over-year revenue decrease to $69.6 million, the stock price fell by $3.94 (57.1%) [6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1]. Group 1: Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, Cardlytics made materially false and misleading statements [1]. - Key allegations include that increasing consumer engagement led to higher consumer incentives, but the company could not increase its billings accordingly, posing a risk of slowed or declining revenue growth [1]. - It is also claimed that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, further misleading investors about the company's business prospects [1]. Group 2: Class Action Details - Shareholders who purchased shares of Cardlytics during the class period are encouraged to register for the class action, with a deadline set for March 25, 2025 [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. - There is no cost or obligation for shareholders to participate in this class action [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Cardlytics, Inc. (NASDAQ: CDLX) securities between March 14, 2024, and August 7, 2024, due to allegations of misleading information regarding the company's business prospects [1][2]. Allegations - The complaint alleges that during the class period, Cardlytics failed to disclose several critical factors: - Increasing consumer engagement led to higher consumer incentives [2] - The company was unable to increase its billings in line with the increased consumer engagement [2] - There was a significant risk that revenue growth would slow or decline as a result [2] - Changes to the Ad Decision Engine, which increased consumer engagement, resulted in "underdelivery" of budgets and customer billing estimates [2] Financial Performance - On August 7, 2024, Cardlytics reported its Q2 2024 financial results, showing a 9% year-over-year revenue decrease to $69.6 million and a 3% decline in adjusted contribution to $36.4 million [3] - Following the announcement, the company's stock price dropped by $3.94, or 57.1%, closing at $2.96 per share on August 8, 2024 [3] Class Action Participation - Shareholders interested in serving as lead plaintiffs must file necessary documents with the court by March 25, 2025 [4] - Participation in the case is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings, leading to a significant risk of revenue growth slowing or declining [2] - Allegations include that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, which misled investors about the company's business prospects [2] Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Summary by Sections Class Action Details - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings, leading to a significant risk of revenue growth slowing or declining [2]. - Specific allegations include that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, making the company's positive statements materially misleading [2]. Next Steps for Investors - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4].

Cardlytics, Inc. (NASDAQ: CDLX ) provides an asymmetric opportunity for investors that are willing to stomach volatility in the stock price and at times slow business progress. I have been long Cardlytics for the last 2My name is Oskar Goyvaerts, and I'm the Chief Investment Officer at Moretus Investments, a value-driven investment firm. I focus on identifying undervalued businesses that are trading far below their intrinsic value. We've been highly successful over the last three years, with recommendations ...

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/cardlytics-lawsuit-subm ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1][2]. Group 1: Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, the defendants made materially false and misleading statements [2]. - Key allegations include that increasing consumer engagement led to higher consumer incentives, but the company could not increase its billings accordingly, posing a risk of revenue growth slowing or declining [2]. - The changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, further misleading investors about the company's business prospects [2]. Group 2: Class Action Details - The deadline for shareholders to register for the class action is March 25, 2025, and they are encouraged to register to monitor the case's progress [3]. - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [3]. - There is no cost or obligation for shareholders to participate in this case [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices [4]. - The firm is committed to ensuring companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflated stock prices [4].

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/cardlytics-lawsuit-submission ...

NEW YORK, Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/cardlytics-loss-submission-form/?id=127852&from=4CLASS PERIOD: March 14, 2024 to August ...